Expression of transmembrane adaptor protein PAG/Cbp in diffuse large B-cell lymphoma: Immunohistochemical study of 73 cases

Pathology Research and Practice

Volumn 203, Issue 4, 2007, Pages 193-198

  Svec, Alexandr ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Diffuse large B cell lymphoma; PAG Cbp; Small cell malignant lymphoma

Indexed keywords

ADAPTOR PROTEIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HUMAN GERMINAL CENTER ASSOCIATED LYMPHOMA PROTEIN; PHOSPHOPROTEIN ASSOCIATED WITH GLYCOSPHINGOLIPID ENRICHED MICRODOMAIN; PROTEIN BCL 6; PROTEIN JAW1; PROTEIN MUM1; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; PHENOTYPE; PROTEIN EXPRESSION;

EID: 34247189616     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2007.01.005     Document Type: Article

References (30)

1. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (2000) 503-511
2. Baumgartner M., Angelisova P., Setterblad N., et al. Constitutive exclusion of Csk from Hck-positive membrane microdomains permits Src kinase-dependent proliferation of Theileria-transformed B lymphocytes. Blood 101 (2003) 1874-1881
3. Behrens T.W., Jagadeesh J., Scherle P., et al. Jaw1, a lymphoid-restricted membrane protein localized to the endoplasmic reticulum. J. Immunol. 153 (1994) 682-690
4. Behrens T.W., Kearns G.M., Rivard J.J., et al. Carboxyl-terminal targeting and novel post-translational processing of JAW1, a lymphoid protein of the endoplasmic reticulum. J. Biol. Chem. 271 (1996) 23528-23534
5. Brdicka T., Pavlistova D., Albrecht L., et al. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase Csk and is involved in regulation of T cell activation. J. Exp. Med. 191 (2000) 1591-1604
6. Chang C.C., McClintock S., Cleveland R.P., et al. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am. J. Surg. Pathol. 28 (2004) 464-470
7. Cheng P.C., Dykstra M.L., Mitchell R.N., et al. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J. Exp. Med. 190 (1999) 1549-1560
8. Davidson D., Bakinowski M., Thomas M.L., et al. Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Mol. Cell Biol. 23 (2003) 2017-2028
9. Dobenecker M.W., Schmedt C., Okada M., et al. The ubiquitously expressed Csk adaptor protein Cbp is dispensable for embryogenesis and T-cell development and function. Mol. Cell Biol. 25 (2005) 10533-10542
10. Gauld S.B., and Cambier J.C. Src-family kinases in B-cell development and signaling. Oncogene 23 (2004) 8001-8006
11. Hans C.P., Weisenburger D.D., Greiner T.C., et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 (2004) 275-282
12. Horejsi V., Zhang W., and Schraven B. Transmembrane adaptor proteins: organizers of immunoreceptor signalling. Nat. Rev. Immunol. 4 (2004) 603-616
13. Jaffe E.S., Harris N.L., Stein H., Vardiman J.W., et al. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumors (2001), IARC Press, Lyon 12-13
14. Kawabuchi M., Satomi Y., Takao T., et al. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 404 (2000) 999-1003
15. Lossos I.S., Alizadeh A.A., Rajapaksa R., et al. HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. Blood 101 (2003) 433-440
16. Lu X., Nechushtan H., Ding F., et al. Distinct IL-4-induced gene expression, proliferation, and intracellular signalling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. Blood 105 (2005) 2924-2932
17. Natkunam Y., Lossos I.S., Taidi B., et al. Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood 105 (2005) 3979-3986
18. Rahmouni S., Vang T., Alonso A., et al. Removal of C-terminal SRC kinase from the immune synapse by a new binding protein. Mol. Cell Biol. 25 (2005) 2227-2241
19. Rosenwald A., Wright G., Chan W.C., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346 (2002) 1937-1947
20. Rosenwald A., Wright G., Leroy K., et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J. Exp. Med. 198 (2003) 851-862
21. Schenten D., Egert A., Pasparakis M., et al. M17, a gene specific for germinal center (GC) B cells and a prognostic marker for GC B-cell lymphomas, is dispensable for the GC reaction in mice. Blood 107 (2006) 4849-4856
22. Staudt L.M., and Dave S. The biology of human lymphoid malignancies revealed by gene expression profiling. Adv. Immunol. 87 (2005) 163-208
23. Svec A., Velenska Z., and Horejsi V. Expression pattern of adaptor protein PAG: correlation between secondary lymphatic follicle and histogenetically related malignant lymphomas. Immunol. Lett. 100 (2005) 94-97
24. Tedoldi S., Paterson J., Cordell J., et al. Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas. J. Pathol. 209 (2006) 454-463
25. Tedoldi S., Paterson J.C., Hansmann M.L., et al. Transmembrane adaptor molecules: a new category of lymphoid-cell markers. Blood 107 (2006) 213-221
26. Torgersen K.M., Vang T., Abrahamsen H., et al. Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src kinase (Csk) from lipid rafts. J. Biol. Chem. 276 (2001) 29313-29318
27. Wright G., Tan B., Rosenwald A., et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc. Natl. Acad. Sci. USA 100 (2003) 9991-9996
28. Xu S., Huo J., Tan J.E., et al. Cbp deficiency alters Csk localization in lipid rafts but does not affect T-cell development. Mol. Cell Biol. 25 (2005) 8486-8495
29. Yasuda K., Nagafuku M., Shima T., et al. Cutting edge: Fyn is essential for tyrosine phosphorylation of Csk-binding protein/phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells. J. Immunol. 169 (2002) 2813-2817
30. Zajchowski L.D., and Robbins S.M. Lipid rafts and little caves. Compartmentalized signalling in membrane microdomains. Eur. J. Biochem. 269 (2002) 737-752